| Inflammatory Mediators and Pain in Endometriosis: A Systematic Review N Machairiotis, S Vasilakaki, N Thomakos Biomedicines 9 (1), 54, 2021 | 84 | 2021 |
| Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2 A Nikolaou, MG Kokotou, S Vasilakaki, G Kokotos Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2019 | 75 | 2019 |
| Development of a potent 2-oxoamide inhibitor of secreted phospholipase A 2 guided by molecular docking calculations and molecular dynamics simulations S Vasilakaki, E Barbayianni, G Leonis, MG Papadopoulos, ... Bioorganic & medicinal chemistry 24 (8), 1683-1695, 2016 | 34 | 2016 |
| Using physics-based pose predictions and free energy perturbation calculations to predict binding poses and relative binding affinities for FXR ligands in the D3R Grand Challenge 2 C Athanasiou, S Vasilakaki, D Dellis, Z Cournia Journal of computer-aided molecular design 32 (1), 21-44, 2018 | 29 | 2018 |
| The design and discovery of phospholipase A2 inhibitors for the treatment of inflammatory diseases CS Batsika, ADD Gerogiannopoulou, C Mantzourani, S Vasilakaki, ... Expert opinion on drug discovery 16 (11), 1287-1305, 2021 | 24 | 2021 |
| The discovery and development of transmembrane serine protease 2 (TMPRSS2) inhibitors as candidate drugs for the treatment of COVID-19 C Mantzourani, S Vasilakaki, VE Gerogianni, G Kokotos Expert Opinion on Drug Discovery 17 (3), 231-246, 2022 | 22 | 2022 |
| Novel Aryl-Substituted Pyrimidones as Inhibitors of 3-Mercaptopyruvate Sulfurtransferase with Antiproliferative Efficacy in Colon Cancer M Bantzi, F Augsburger, J Loup, Y Berset, S Vasilakaki, ... Journal of Medicinal Chemistry 64 (9), 6221-6240, 2021 | 17 | 2021 |
| Natural products: Potential lead compounds for the treatment of endometriosis N Machairiotis, S Vasilakaki, P Kouroutou European Journal of Obstetrics & Gynecology and Reproductive Biology 245, 7-12, 2020 | 17 | 2020 |
| Genes’ Interactions: A Major Contributor to the Malignant Transformation of Endometriosis K Sapalidis, N Machairiotis, P Zarogoulidis, S Vasilakaki, C Sardeli, ... International journal of molecular sciences 20 (8), 1842, 2019 | 14 | 2019 |
| Inhibitors of secreted phospholipase A 2 suppress the release of PGE 2 in renal mesangial cells S Vasilakaki, E Barbayianni, V Magrioti, O Pastukhov, ... Bioorganic & medicinal chemistry, 2016 | 13 | 2016 |
| Small Peptides Able to Suppress Prostaglandin E2 Generation in Renal Mesangial Cells S Vasilakaki, O Pastukhov, T Mavromoustakos, A Huwiler, G Kokotos Molecules 23 (1), 158, 2018 | 9 | 2018 |
| Nutrients that modulate gestational diabetes mellitus: A systematic review of cohort studies Jan 2019‐Jan 2020 N Machairiotis, S Vasilakaki, L Minns, A Malakasis International Journal of Clinical Practice 75 (8), e14033, 2021 | 8 | 2021 |
| A facile consensus ranking approach enhances virtual screening robustness and identifies a cell-active DYRK1α inhibitor M Mavrogeni, F Pronios, D Zareifi, S Vasilakaki, O Lozach, L Alexopoulos, ... Future Medicinal Chemistry, 0 | 8* | |
| α-Ketoheterocycles Able to Inhibit the Generation of Prostaglandin E2 (PGE2) in Rat Mesangial Cells A Psarra, MA Theodoropoulou, M Erhardt, M Mertiri, C Mantzourani, ... Biomolecules 11 (2), 275, 2021 | 2 | 2021 |
| Inflammatory Mediators and Pain in Endometriosis: A Systematic Review. Biomedicines 2021, 9, 54 N Machairiotis, S Vasilakaki, N Thomakos s Note: MDPI stays neu-tral with regard to jurisdictional clai-ms in …, 2021 | 2 | 2021 |
| Hydration thermodynamics of cytosolic phospholipase A2 GIVA predict its membrane-associated parts and its highly hydrated binding site S Vasilakaki, J Kraml, M Schauperl, KR Liedl, G Kokotos Journal of Biomolecular Structure and Dynamics 39 (3), 953-959, 2021 | 1 | 2021 |
| α-Ketoheterocycles Able to Inhibit the Generation of Prostaglandin E2 (PGE2) in Rat Mesangial Cells. Biomolecules 2021, 11, 275 A Psarra, MA Theodoropoulou, M Erhardt, M Mertiri, C Mantzourani, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | | 2021 |
| Corrigendum to" Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2"[Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1864 … A Nikolaou, MG Kokotou, S Vasilakaki, G Kokotos Biochimica et biophysica acta. Molecular and cell biology of lipids 1864 (11 …, 2019 | | 2019 |
| Computer-aided drug design to predict binding poses and relative binding affinities for FXR ligands in the D3R Grand Challenge 2 C Athanasiou, S Vasilakaki, D Dellis, Z Cournia BRFAA, 2017 | | 2017 |
| Inhibition of GIIA phospholipase A2 by 2-oxoamides based on a-amino acids: Exploring the role of the a-amino acid S Vasilakaki, N Stavrinoudakis, E Barbayianni, T Mavromoustakos, ... | | 2016 |
